Search results

This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care.

Result type

NICE guideline

Published

19 July 2017

This quality standard covers the management of Parkinson’s disease in adults. It does not include treatment of parkinsonism not caused by Parkinson’s disease. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

9 February 2018

All NICE products on parkinson's disease, tremor and dystonia. Includes any guidance, advice and quality standards.

Result type

Topic page

Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT-ON (Sense4care) for remote monitoring of Parkinson’s disease

Result type

Diagnostics guidance

Last updated

25 January 2024

Evidence-based recommendations on subthalamotomy for Parkinson's disease. This involves putting very thin needles into the brain through small holes made in the skull.

Result type

Interventional procedures guidance

Published

23 June 2004

Awaiting development [GID-IPG10375] Expected publication date: 12 December 2024

Result type

Interventional procedures guidance

Status

Awaiting development

This guideline covers diagnosing and managing dementia (including Alzheimer’s disease). It aims to improve care by making recommendations on training staff and helping carers to support people living with dementia.

Result type

NICE guideline

Published

20 June 2018

Suggested remit: To appraise the clinical and cost effectiveness of levodopa, carbidopa monohydrate and entacapone within its marketing authorisation for treati...

Result type

Technology appraisal guidance

Status

Topic selection

NICE has developed a medtech innovation briefing (MIB) on Path Finder for freezing of gait in people with Parkinson’s disease .

Result type

Medtech innovation briefing

Published

25 January 2019

Evidence-based recommendations on deep brain stimulation for Parkinson's disease. This involves planting electrodes into the brain and generating electrical currents to reduce the problems caused by Parkinson's disease

Result type

Interventional procedures guidance

Published

26 November 2003

Evidence-based recommendations on foslevodopa–foscarbidopa (Produodopa) for treating advanced Parkinson’s with motor symptoms in adults.

Result type

Technology appraisal guidance

Published

29 November 2023

Evidence-based recommendations on unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson’s disease in adults. This involves applying ultrasound to a specific area on 1 side of the brain (thalamus).

Result type

Interventional procedures guidance

Published

28 February 2018

Evidence-based recommendations on deep brain stimulation for tremor and dystonia (excluding Parkinson's disease). This involves planting electrodes in the brain and generating electrical currents to help control the tremor or dystonia.

Result type

Interventional procedures guidance

Published

23 August 2006

Register an interest in this interventional procedure   ...

Result type

Interventional procedures guidance

Status

Topic selection

Awaiting development [GID-IPG10402] Expected publication date: 12 December 2024

Result type

Interventional procedures guidance

Status

Awaiting development